Online Inquiry
Cat.#: ASSD-140
| Description | A2B covalent ligand selectively targets lysine residue(s) on the receptor and binds persistently in radioligand displacement and wash-out assays, allowing for novel ways to interrogate the A2BAR. Apparent pKi values at A2BARs are 8.10 and 9.17 (after 4h), where a Ki shift indicates a covalent mode of action. Displays ~100 -fold selectivity for A2B compared to A1, A2A and A3 receptors. |
| Size | 50 μg |
| Chemical Name | 4-(2,6-dioxo-1-propyl-2,3,6,7-tetrahydro-1H-purin-8-yl)benzenesulfonyl fluoride |
| Molecule Weight | 352.3 |
| Molecular formula | C14H13FN4O4S |
| Purity | >95% |
| Solubility | Soluble in DMSO |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-171 | Ionomycin calcium salt (AC171) | 1mg, 5mg | inquiry |
| ASSD-139 | Adenosine A1AR Affinity-Based Probe (AfBP) (AC139) | 50 μg | inquiry |
| ASSD-193 | N-(Aminoethyl)-5-naphthylamine-1-sulfonic Acid (AC193) | 1 g | inquiry |
| ASSD-101 | Cresyl Violet Solution (1%) (AC101) | 250 mL, 500 mL, | inquiry |
| ASSD-156 | Crystal Violet (AC156) | 1g, 5g | inquiry |
| ASSD-120 | Fluorescent adenosine antagonist [XAC] (AC120) | 500 μg | inquiry |
| ASSD-128 | Fluorescent M3 antagonist [pirenzepine] (AC128) | 50 μg | inquiry |
| ASSD-175 | 5-Carboxyfluorescein-N-hydroxysuccinimide Ester (AC175) | 25 mg | inquiry |
| ASSD-189 | 7-Hydroxycoumarin-3-carboxylic acid (AC189) | 100 mg | inquiry |
| ASSD-186 | Bromocresol Purple (AC186) | 5 g, 10 g | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.